By day, she administers home care services to patients who depend on the program; and by night, she relies on the same ...
Q4 2024 Earnings Call Transcript March 27, 2025 P3 Health Partners Inc. misses on earnings expectations. Reported EPS is ...
A bill contends it could reduce the cost of hospital stays for patients in the Public Employees’ Benefits Program by capping ...
Lake Street analyst Brooks O’Neil maintained a Buy rating on P3 Health Partners (PIII – Research Report) today and set a price target of $1.00.
William Blair analyst Ryan Daniels maintained a Buy rating on P3 Health Partners (PIII – Research Report) today. The company’s shares closed ...
Q4 2024 Management View CEO Aric Coffman highlighted the company's focus on achieving near-term profitability, supported by programmatic initiatives targeting over $130 million in adjusted EBITDA ...
Good day and welcome to the P3 Health Partners’ Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there ...
Shares of P3 Health Partners were trading at $0.1829 as of March 25. Over the last 52-week period, shares are down 82.58%.
On Monday, BTIG downgraded P3 Health Partners Inc (NASDAQ:PIII) from Buy to Neutral following the company's fourth-quarter ...
The University of Nevada ... million in P3 funding for two projects and infrastructure work. At the same time, the University of Iowa is also in litigation with one of its P3 partners, the ...
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results